Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prochymal in newly diagnosed acute GVHD
NCT00562497Phase 3Completed
- Sponsor
- Mesoblast Ltd
- Start
- Jan 2008
- Primary completion
- Jul 2009
- Modality
- Stem Cell Therapies
- Countries
- 3
01
Overview
A Phase 3 trial of remestemcel-L-rknd in Acute Graft-Versus-Host Disease (aGvHD), sponsored by Mesoblast Ltd. Started Jan 2008; status: completed.
02
Drugs
remestemcel-L-rknd
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT00562497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00562497.